|
µî·ÏÀÏ:
2004-06-21 14:26:41 , Á¶È¸:
5,604 |
¾ÆÅäÇǼº ÇǺο° ¸ðµ¨ ¸¶¿ì½ºÀÎ NC/NGA ¸¶¿ì½º¿¡°Ô °¨ÀÙÀ» ¸Ô¿´À»¶§ ³ªÅ¸³ª´Â ÇǺÎÁõ»óÀÇ °æ°¨È¿°ú¿Í ÇǺÎÀÇ ¼öºÐ ¼Õ½Ç °æ°¨È¿°ú.
Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga.
Br J Dermatol. 2002 Feb; 146(2): 221-7.
Matsumoto M, Kotani M, Fujita A, Higa S, Kishimoto T, Suemura M, Tanaka T.
ÀϺ» ¿À»çÄ« ¿¬±¸¿Í °³¹ß ¼¾ÅÍ,
Research and Development Center, Sunstar Incorporation, Osaka, Japan.
¿¬±¸ ¹è°æ: ¿ì¸®´Â ÀÌÀü¿¡ °¨ÀÙ ÃßÃâ¹°¹× °¨ÀÙÀÇ Áֿ伺ºÐÀÎ ÈĶ󺸳ëÀÌµå ¼ººÐÀÎ ¾Æ½ºÆ®¶ó°¥¸°ÀÌ È£¿°±â±¸¸¦ ÅëÇÏ¿©¼ È÷½ºÅ¸¹Î ºÐºñ¸¦ ¾ïÁ¦ÇÑ´Ù´Â °ÍÀ» º¸°íÇÏ¿´´Ù. ±×¸®°í ÀÌ°ÍÀ» ¾ÆÅäÇÇ À¯¹ßµÈ Áã¿¡°Ô ÀÔÀ¸·Î ¸Ô¿´À»¶§ ¾ÆÅäÇÇÀÇ ¿¹¹æ¿¡ µµ¿òÀÌ µÈ´Ù´Â°ÍÀ» º¸°íÇѹ٠ÀÖ´Ù.
¿¬±¸ ¸ñÇ¥: ÀÌ ¿¬±¸´Â °¨ÀÙÂ÷¿Í ±× ÁÖ¼ººÐÀÎ ¾Æ½ºÆ®¶ó °¥¸°ÀÇ ÀÓ»óÀû °¡Ä¡¸¦ Æò°¡ÇÏ°íÀÚ µðÀÚÀÎ µÇ¾ú´Ù. ¾ÆÅäÇÇ°¡ À¯¹ßµÈ ¸¶¿ì½º¿¡°Ô °¨ÀÙÂ÷¿Í ¾Æ½ºÆ®¶ó°¥¸°À» ¿ë·®À» ´Þ¸®ÇÏ¿© °¡¸é¼ ¾ÆÅäÇÇ ÇǺλóÅÂ¿Í ÇǺÎÀÇ ¼öºÐ¼Õ½Ç»óŸ¦ Á¶»çÇÏ¿´´Ù.
¿¬±¸ ¹æ¹ý: ¾ÆÅäÇÇ À¯¹ßµÈ ¸¶¿ì½ºÀÇ ÇǺθ¦ ±Ü´Â Á¤µµ, Ç÷û³» IgE Á¤µµ, TEFL(ÇǺÎÀÇ ¼öºÐ¼Õ½Ç)À» ÃøÁ¤ÇÏ¿© °¨ÀÙÂ÷¿Í ¾Æ½ºÆ®¶ó°¥¸°ÀÇ È¿°ú¸¦ ÃøÁ¤ÇÏ¿´´Ù.
°á°ú: 4ÁÖµ¿¾ÈÀÇ °¨ÀÙÂ÷³ª ¾Æ½ºÆ®¶ó°¥¸°ÀÇ º¹¿ëÀº ¾ÆÅäÇÇ ¸¶¿ì½ºÀÇ ÇǺμջóÀ» ¸¹ÀÌ ¾ïÁ¦ÇÏ¿© ÁÖ¾ú´Ù.±×¸®°í ÀÌ·± ¾ïÁ¦È¿°ú´Â ¿ë·®¿¡ ºñ·ÊÇÏ¿© È¿°ú°¡ ³ªÅ¸³µ´Ù. ±×¸®°í ²ÙÁØÈ÷ °¨ÀÙÂ÷¸¦ º¹¿ëÇÏ¿´´õ´Ï ¾ÆÅäÇÇ Ãʱâ¹ßÇöÀ» ¾ïÁ¦ÇÏ°í ¾ÆÅäÇÇ·ÎÀÇ ¹ßÀüµÇ´Â°ÍÀ» ¾ïÁ¦ÇÏ¿´´Ù. °Ô´Ù°¡ ÇǺÎÀÇ ¼öºÐ¼Õ½Çµµ ¸¹ÀÌ °æ°¨½ÃÄÑÁÖ¾ú´Ù.
±×¸®°í ¶Ñ·ÇÇÑ ÀÌ»ó¹ÝÀÀÀº ³ªÅ¸³ªÁö ¾Ê¾Ò´Ù.
°á·Ð: ÀÌ·± °á°ú¸¦ ÅëÇؼ º¼¶§ °¨ÀÙÂ÷³ª ÀÌÀÇ ÁÖ¼ººÐÀÎ ¾Æ½ºÆ®¶ó °¥¸°Àº ¾ÆÅäÇǼº ÇǺο°ÀÇ °ü¸®¿¡ ¾ç¹æÄ¡·á¸¦ ´ëüÇÒ¸¸ÇÑ ÁÁÀº ¹°ÁúÀÌ µÉ°ÍÀ¸·Î º¸¿©Áø´Ù.
Oral administration of persimmon leaf extract ameliorates skin symptoms and transepidermal water loss in atopic dermatitis model mice, NC/Nga.
Br J Dermatol. 2002 Feb; 146(2): 221-7.
Matsumoto M, Kotani M, Fujita A, Higa S, Kishimoto T, Suemura M, Tanaka T.
BACKGROUND: We have previously shown that persimmon leaf extract and its major flavonoid constituent, astragalin, inhibited histamine release by basophils and that oral administration of these substances prior to the onset into an atopic dermatitis (AD) model mouse, NC/Nga, prevented development of dermatitis. OBJECTIVES: This study was designed to assess the clinical therapeutic effect of persimmon leaf extract and astragalin in NC/Nga mice suffering from dermatitis and the dose-response preventive effects of persimmon leaf extract on dermatitis and transepidermal water loss (TEWL). METHODS: The efficacy of persimmon leaf extract or astragalin in NC/Nga mice was judged by measurement of skin severity, scratching behaviour, serum IgE levels or TEWL. RESULTS: Oral administration of persimmon leaf extract (250 mg kg(-1)) or astragalin (1.5 mg kg-1) for 4 weeks into NC/Nga mice with overt dermatitis resulted in a decrease in the severity of the condition. The preventive effect of persimmon leaf extract on the dermatitis was dose-dependent and continuous intake of persimmon leaf extract significantly decreased its onset and development. In addition, TEWL was also suppressed at a persimmon leaf extract dose of 250 mg kg(-1). No significant adverse reaction by these substances could be observed. CONCLUSIONS: These observations suggest that persimmon leaf extract or the flavonoid astragalin may be alternative substances for the management of AD.
º» ±ÛÀº ³ë¾ÆÇÑÀÇ¿ø(http://www.atopynara.com)ÀÇ ÀÌÇü¼® ¿øÀå´Ô²²¼ ¹ø¿ªÇÏ¿© Á¦°øÇØÁֽŠ±ÛÀÔ´Ï´Ù.
|
|